Glucagon-Like Peptide-1 Receptor Agonists and Risk of Macular Degeneration
jamanetwork.com
jamanetwork.com
Emphasis mine, but it's important context that probably wouldn't fit in the title.
Of course hard to extrapolate to the general case from this study, as it only included patients over 66 with a diagnosis of diabetes.